Targeting the Wnt/frizzled signaling pathway after myocardial infarction: A new tool in the therapeutic toolbox?

Trends in Cardiovascular Medicine

Volumn 23, Issue 4, 2013, Pages 121-127

  Daskalopoulos, Evangelos P ^a   Hermans, Kevin C M ^a   Janssen, Ben J A ^a   Matthijs Blankesteijn, W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CASEIN KINASE I; COLLAGEN TYPE 1; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN RECEPTOR; PYRVINIUM EMBONATE; SECRETED FRIZZLED RELATED PROTEIN 2; WNT PROTEIN;

CELL CYCLE REGULATION; CELL MEMBRANE; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; COLON POLYPOSIS; CYTOPLASM; DRUG TARGETING; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART RUPTURE; HUMAN; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STEM CELL; TREATMENT DURATION; WNT SIGNALING PATHWAY;

ADULT; ANIMALS; DRUG DISCOVERY; FRIZZLED RECEPTORS; HEART FAILURE; HUMANS; MOLECULAR TARGETED THERAPY; MYOCARDIAL INFARCTION; MYOCARDIUM; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84875891536     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.09.010     Document Type: Review

References (42)

1. Alfaro M.P., Pagni M., Vincent A., Atkinson J., Hill M.F., Cates J, et al. The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:18366-18371.
2. Alfaro M.P., Vincent A., Saraswati S., Thorne C.A., Hong C.C., Lee E., et al. sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. Journal of Biological Chemistry 2010, 285:35645-35653.
3. Barandon L., Casassus F., Leroux L., Moreau C., Allieres C., Lamaziere J.M., et al. Secreted frizzled-related protein-1 improves postinfarction scar formation through a modulation of inflammatory response. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:e80-87.
4. Barandon L., Couffinhal T., Ezan J., Dufourcq P., Costet P., Alzieu P., et al. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. Circulation 2003, 108:2282-2289.
5. Blankesteijn W.M., Essers-Janssen Y.P., Verluyten M.J., Daemen M.J., Smits J.F. A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nature Medicine 1997, 3:541-544.
6. Bovolenta P., Esteve P., Ruiz J.M., Cisneros E., Lopez-Rios J Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. Journal of Cell Science 2008, 121:737-746.
7. Bui A.L., Horwich T.B., Fonarow G.C. Epidemiology and risk profile of heart failure. Nature Reviews Cardiology 2011, 8:30-41.
8. Cho J., Zhai P., Maejima Y., Sadoshima J. Myocardial injection with GSK-3beta-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. Circulation Research 2011, 108:478-489.
9. Cleutjens J.P., Blankesteijn W.M., Daemen M.J., Smits J.F. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovascular Research 1999, 44:232-241.
10. Clevers H., Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-1205.
11. Daskalopoulos E.P., Janssen B.J., Blankesteijn W.M. Myofibroblasts in the infarct area: concepts and challenges. Microscopy and Microanalysis 2012, 18:35-49.
12. Eisenberg L.M., Eisenberg C.A. Wnt signal transduction and the formation of the myocardium. Developmental Biology 2006, 293:305-315.
13. Gajarsa J.J., Kloner R.A. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Failure Reviews 2011, 16:13-21.
14. Hahn J.Y., Cho H.J., Bae J.W., Yuk H.S., Kim K.I., Park K.W., et al. Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. Journal of Biological Chemistry 2006, 281:30979-30989.
15. He W., Zhang L., Ni A., Zhang Z., Mirotsou M., Mao L., et al. Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:21110-21115.
16. He X., Semenov M., Tamai K., Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004, 131:1663-1677.
17. Heallen T., Zhang M., Wang J., Bonilla-Claudio M., Klysik E., Johnson R.L., et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332:458-461.
18. http://www.stanford.edu/group/nusselab/cgi-bin/wnt/target_genes.
19. Jain M., Liao R., Podesser B.K., Ngoy S., Apstein C.S., Eberli F.R. Influence of gender on the response to hemodynamic overload after myocardial infarction. American Journal of Physiology: Heart and Circulatory Physiology 2002, 283:H2544-2550.
20. Katz A.M., Konstam M.A. Heart failure: pathophysiology, molecular biology, and clinical management 2009, Lippincott Williams, Philadelphia. 2nd edition.
21. Kikuchi A., Yamamoto H., Kishida S. Multiplicity of the interactions of Wnt proteins and their receptors. Cellular Signalling 2007, 19:659-671.
22. Kimelman D., Xu W. Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 2006, 25:7482-7491.
23. Kobayashi K., Luo M., Zhang Y., Wilkes D.C., Ge G., Grieskamp T., et al. Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nature Cell Biology 2009, 11:46-55.
24. Koval A., Purvanov V., Egger-Adam D., Katanaev V.L. Yellow submarine of the Wnt/Frizzled signaling: submerging from the G protein harbor to the targets. Biochemical Pharmacology 2011, 82:1311-1319.
25. Kuwahara K., Nakao K. New molecular mechanisms for cardiovascular disease:transcriptional pathways and novel therapeutic targets in heart failure. Journal of Pharmacological Sciences 2011, 116:337-342.
26. Laeremans H., Hackeng T.M., van Zandvoort M.A., Thijssen V.L., Janssen B.J., Ottenheijm H.C., et al. Blocking of frizzled signaling with a homologous peptide fragment of Wnt3a/Wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 2011, 124:1626-1635.
27. Laeremans H., Rensen S.S., Ottenheijm H.C., Smits J.F., Blankesteijn W.M. Wnt/frizzled signalling modulates the migration and differentiation of immortalized cardiac fibroblasts. Cardiovascular Research 2010, 87:514-523.
28. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Developmental Cell 2009, 17:9-26.
29. McMurray J.J., Pfeffer M.A. Heart failure. Lancet 2005, 365:1877-1889.
30. Meijer L., Flajolet M., Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends in Pharmacological Sciences 2004, 25:471-480.
31. Mikels A.J., Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 2006, 25:7461-7468.
32. Murry C.E., Pu W.T. Reprogramming fibroblasts into cardiomyocytes. New England Journal of Medicine 2011, 364:177-178.
33. Nusse R., Varmus H.E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982, 31:99-109.
34. Oikonomopoulos A., Sereti K.I., Conyers F., Bauer M., Liao A., Guan J., et al. Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circulation Research 2011, 109:1363-1374.
35. Povelones M., Nusse R. The role of the cysteine-rich domain of Frizzled in Wingless-Armadillo signaling. EMBO Journal 2005, 24:3493-3503.
36. Rao T.P., Kuhl M. An updated overview on Wnt signaling pathways: a prelude for more. Circulation Research 2010, 106:1798-1806.
37. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
38. Saraswati S., Alfaro M.P., Thorne C.A., Atkinson J., Lee E., Young P.P. Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PLoS One 2010, 5:e15521.
39. van de Schans V.A., Smits J.F., Blankesteijn W.M. The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe?. European Journal of Pharmacology 2008, 585:338-345.
40. Woulfe K.C., Gao E., Lal H., Harris D., Fan Q., Vagnozzi R., et al. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo. Circulation Research 2010, 106:1635-1645.
41. Zelarayan L.C., Noack C., Sekkali B., Kmecova J., Gehrke C., Renger A., et al. Beta-catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19762-19767.
42. Zuo S., Jones W.K., Li H., He Z., Pasha Z., Yang Y., et al. Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury. Stem Cells and Development 2012, 21:598-608.